Skip to main content

Lucid Diagnostics Inc. (LUCD)

NASDAQ: LUCD · IEX Real-Time Price · USD
9.55
+0.02 (0.21%)
After-hours:Oct 20, 2021 6:48 PM EDT
9.53
0.10 (1.06%)
At close: Oct 20, 4:00 PM
Market Cap349.98M
Revenue (ttm)n/a
Net Income (ttm)-14.57M
Shares Out36.72M
EPS (ttm)-0.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume297,301
Open9.50
Previous Close9.43
Day's Range9.10 - 9.66
52-Week Range9.10 - 13.52
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About LUCD

Lucid Diagnostics is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). We believe that our lead products, the EsoGuard® Esophageal DNA Test performed on samples collected with the EsoCheck® Esophageal Cell Collection Device, constitute the first and only commercially avail...

IndustryMedical Devices
IPO DateOct 14, 2021
CEOLishan Aklog, M.D.
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolLUCD
Full Company Profile

Financial Performance

Financial Statements

News

Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering

NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM...

2 days ago - GlobeNewsWire

LUCD Stock IPO: 7 Things to Know as Lucid Diagnostics Starts Trading Today

Unfortunately, today is a very red day for investors who got in on the recent LUCD stock IPO, with shares of this stock down more than 17%. The post LUCD Stock IPO: 7 Things to Know as Lucid Diagnostics...

6 days ago - InvestorPlace

Lucid Diagnostics Announces Pricing of Initial Public Offering

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the pri...

1 week ago - Business Wire

Lucid Diagnostics IPO Registration Document (S-1)

Lucid Diagnostics Inc. has filed to go public with an IPO on the NASDAQ.

4 weeks ago - SEC